Answers are grounded in this paper and cite their sources.
Study advocates testing medical AI for causal alignment, indicating the need for better validation methods.
Medical AI often optimizes end-to-end performance while offering post-hoc explanations, widening an epistemic gap between behavior and justified clinical claims. Interpretable models and XAI help, but are insufficient. We advocate governance by testability: preregistered empirical trials of causal alignment (avoiding shortcuts) and invariance across scanners, sites, and subgroups, plus monitoring and rollback. We propose Institutional AI—auditable provenance, prospective validation, external audits, and analogous adversarial evaluations for LLMs.
No takes yet. Share an insight, caveat, or question.
Pesapane et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: